“THE SYNTHESIS A SERIES OF 2 – ANILINOPHENYLACETIC ACID DERIVATIVS FOR THEIR ANTIMICROBIAL ACTIVITY”

Keywords

Abstract

References

1. [1]1. Borne R. Nonsteroidal anti-inflammatory agents. In: William DA, Lemke TL, editors. Foye’s principal of medicinal chemistry. 5th ed. New Delhi: Lippincott Williams and Wilkins; 2007. p. 768-769.
2. [2]2. Hanson GR. Analgesic, antipyretic, and anti-inflammatory drug. In: Gennaro AR, editor. Remington: the science and practice of pharmacy. 20th ed. Philadelphia: Lippincott Williams and Wilkins; 2000. p. 1454.
3. [3]3. Tripathi KD. Essentials of medical pharmacology. 5th ed. New Delhi: jaypee Brothers; 2003. p. 168-170.
4. [4]4. Tacconelli S, Capone ML, Patrimani P. Clinical pharmacology of novel selective COX-2 inhibitors. Curr Pharm Des 2004; 10: 589-601.
5. [5]5. O’Neill LA. Targeting signal transduction as a strategy to treat inflammatory disease. Nat Rev Drug Discovery 2006; 5: 549-563.
6. [6]6. Keeble JE, Moore PK. Pharmacology and potential therapeutic application of nitric oxide releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs. Brit J Pharmacol 2002; 137: 295-310.
7. [7]7. Hamor GN. Nonsteroidal anti-inflammatory drug. In: Foye WO, editor. Principles of medicinal chemistry. 3rd ed. Bombay: Varghese Publishing House; 1989. p. 525.
8. [8]8. Sriram D, Yogeeswari P, Devekaram RV. Synthesis, in vitro and in vivo antimycobacterial activities of diclofenac acid and amides. Bioorganic and Med Chem 2006; 14: 3113-3118.
9. [9]9. Dutta NK, Kumar A, Mazumdar K, Dastidar SG. Invitro and invivo antimycobacterial drug, diclofenac sodium. Indian J Experi Bio 2004; 42: 922-927.
10. [10]10. Sidhapuriwala J, Li L, Sparatore A, Bhatia M, Moore PK. Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative, on carrageenam-induced hindpaw oedema formation in the rat. Europ J Pharmacol 2007; 569: 149-154.
11. [11]11. Li L, Rossoni G, Saparatore A, Lee LC, Soldato PD, Moore PK. Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative. Free Rad Bio and Med 2007; 42: 706-719.
12. [12]12. Amir M, Shikha K. Synthesis and anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation activities of some new 2-[(2,6-dichloroanilino) phenyl]acetic acid derivatives. Europ J Med Chem 2004; 39: 535-545.
13. [13]13. Vogel H G. Drug discovery and evaluation: Pharmacological Assay. 2nd ed. Heidelberg: Springer. 2002. 716-717,770-771,759-761.
14. [14]14. Wermuth C G. In medicinal chemistry: definition and objectives, the three main phases of drug activity, drug and disease classifications. In: Wermuth C G, editor. The practice of medicinal chemistry. 2nd ed. Avon: Bath press. 2003. 29-32.
15. [15]15. Basu S, Oyelere A K. Application of Recombinant DNA Technology in Medicinal Chemistry and Drug Discovery. In Abraham D J, editor. In: Burgers medicinal chemistry and drug discovery. Vol- 2, Drug discovery and development. 6th ed. John wiley and sons. 87 (Structure of cox2).
16. [16]16. Bell R L, Harris R R, Stewart A O. COX-2 inhibitors and leukotriene modulators. In Abraham D J, editor. In: Burgers medicinal chemistry and drug discovery. Vol- 4, Autocoids, diagnostics, and drugs from new biology. 6th ed. John wiley and sons. 229- 250. (cox2).
17. [17]17. Trevor A J, Katzung B G, Masters S B. Katzung & trevors: Pharmacology, examination & board review. 6th ed. New York: Lange Medical Books/McGraw-Hill. 2002. 174-177, 323-327.
18. [18]18. Mycek M J, Harvey R A, Champe P C. Lippincott's illustrated reviews: Pharmacology. 2nd ed. Philadelphia: Lippincott williams & wilkins. 2000. 401-417.
19. [19]19. Gund T. Molecular modeling of small molecules. In Cohen N C, editor. In Molecular modeling and drug design. 55-82.
20. [20]20. Tollenaere J P. Glossary of terminology. In Cohen N C, editor. In Molecular modeling and drug design. 337.
21. [21]21. Lullmann H, Mohr K, Ziegler A, Bieger D. Color atlas of pharmacology. 2nd ed. New York: Thieme Stuttgart. 2000. 195, 201.
22. [22]22. Thomas G. Fundamentals of medicinal chemistry. 1st ed. Chichester: John Wiley & Sons Ltd. 2003. 71-73.
23. [23]23. Moser P, Sallmann A, Wiesenberg. Synthesis and quantitative structure activity relationship of diclofenac analogues. J Med Chem 1990; 33: 2358-2368.
24. [24]24. Han S Y, Inoue H et al. N-benzylideneaniline and N-benzylaniline are potent inhibitors of lignostilbene-alpha,beta-dioxygenase, a key enzyme in oxidative cleavage of the central double bond of lignostilbene. J Enzyme Inhib Med Chem 2003;18 (3): 279-83.
25. [25]25. Ahmed F, Magid A et al. Reductive amination of aldehyde and ketones with sodium triacetoxyborohydride. Studies on direct and indirect reductive amination procedures. J Org Chem 1996; 61: 3849-3862.
26. [26]26. Varma R S, Dahiya R. Sodium borohydride on wet clay: Solvent free reductive amination of carbonyl compounds using microwaves. Tetrahedron 1998; 54: 6293-6298.
27. [27]27. Yang H J, Sun W H, Li Z L, Ma Z. The rapid synthesis of Schiff-base without solvent under microwave irradication. Chin Chem Lett 2002; 13: 3-6.
28. [28]28. Failli A A. US patent No. US5021576, 1991.
29. [29]29. Sallamann A, Bottminger, Basel- land, Pfister R. US patent No. US3536758, 1970.
30. [30]30. Sato A, McNulty L, Cox K, Kim S, Scott A, Daniell K, Summerville K, Price C, Hudson S, Kiakos K, Hartley JA, Asao T, Lee M. A novel class of in vivo active anticancer agents: achiral seco-amino- and seco-hydroxycyclopropylbenz[e]indolone (seco-CBI) analogues of the duocarmycins and CC-1065. J Med Chem 2005; 48(11): 3903-18.
31. [31]31. Mewshaw R E. US patent No. US 5817690, 1998.
32. [32]32. Abadi A H, Abou-Seri S M, Abdel-Rahman D E, Klein C, Lozach O, Meijer L. Synthesis of 3-substituted-2-oxoindole analogues and their evaluation as kinase inhibitors, anticancer and antiangiogenic agents. Europ J Med Chem 2006; 41(3): 296-305.
33. [33]33. Manoury P, Binet J, Daniel O, Defosse G, Dewitte E, Veronique C. US patent No. US5010079, 1991.
34. [34]34. Dermatakis A, Kin-Chun L, DePinto W. Synthesis of Potent Oxindole CDK2 Inhibitors. Bioorg & med chem 2003; 11: 1873-1881.
35. [35]35. Demarinis R M, Gallagher G J, Hall R F, Franz R G, Webster C, Huffman W F, Schwartz M S, Kaiser C, Ross S T, Wilson J W. Syntheses and in vitro evaluation of 4-(2-aminoethyl)-2(3H)-indolones and related compounds as peripheral prejunctional dopamine receptor agonists. J Med Chem 1986; 29(6): 939-47.
36. [36]36. Soliman F S, Salama H M. Novel indolene-spiro-hydroxytetronimides as potential antineoplastic and antiviral agents. Pharmazie 1983; 38(9): 585-6.
37. [37]37. Radwan M A A, Ragab E A, Sabry N M, El-shenawy S M. Synthesis and biological evaluation of new 3-substituted indole derivatives as potential anti- inflammatory and analgesic agents. Bioorg & med chem 2007; 15: 3832-3871.
38. [38]38. Karali N, Gursoy A et al. Synthesis and structure–antituberculosis activity relationship of 1H-indole-2,3-dione derivatives. Bioorg & med chem 2007; 15: 5888-5904.
39. [39]39. Karali N. Synthesis and primary cytotoxicity evaluation of new 5-nitroindole- 2,3-dione derivatives. Europ J Med Chem 2002; 37: 909-/918.
40. [40]40. Yong S R, Ung A T, Pyne S G, Skelton B W, White A H. Synthesis of novel 3-spirocyclic-oxindole derivatives and assessment of their cytostatic activities. Tetrahedron 2007; 63: 5579–5586.
41. [41]41. Konstantinos K, Atsushi S, Tetsuji A, McHugh P J, Moses L, Hartley J A. DNA sequence selective adenine alkylation, mechanism of adduct repair, and in vivo antitumor activity of the novel achiral seco-amino-cyclopropylbenz[e]indolone analogue of duocarmycin AS-I-145. Mol canc therap 2007; 6 (10): 2708-2718.
42. [42]42. Lundbeck H, Konkel M, Mathivanan P. WIPO, WO/2006/083538.
43. [43]43. Bauer AW, Kirby W M, Shersis J C, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathal 1996; 45(4):493-496.
44. [44]44. Indian Pharmacopoeia 1996. Vol. II. Delhi: The Controller of publications. Appendix 9.1; A 105-107.
45. [45]45. Pelczar M J, Chan E C S, Kriey N R. Microbiology. 5th ed. New Delhi: Tata Mcgraw Hill Publication Company ltd. 1993. 133-149.
46. [46]46. Ananthanarayan R, Panikar C K J. Text Book of Microbiology. 7th ed. Hyderabad: Orient Longman Publication. 2005. 34-38.
47. [47]47. Stanier R Y, Ingraham J L, Wheelis M L, Paiter P R. General Microbiology. 5th ed., London: Macmillan Press Ltd. 1987. 12-37.
48. [48]48. Bolton S. Pharmaceutical statistics: Practical and clinical application. 2005. New york: Marcel Dekker Inc,: pp 444-489.
49. [49]49. Muth J., Basic statics and pharmaceutical statical applications, New York: Marcel Dekker Inc,: pp 170-172.
50. [50]50. Rang and dale pharmacology.

Authors (4)